PubMed=26095605; DOI=10.1016/j.stemcr.2015.05.010; PMCID=PMC4618251
Carlo Cusulin, Charles Chesnelong, Pinaki Bose, Misha Bilenky, Karen Kopciuk, Jennifer Ai-Wen Chan, J. Gregory Cairncross, Steven J.M. Jones, Marco Antonio Marra, Hema Artee Luchman, Samuel Weiss;
Precursor states of brain tumor initiating cell lines are predictive of survival in xenografts and associated with glioblastoma subtypes.
Stem Cell Reports 5:1-9(2015)

PubMed=26245525; DOI=10.1093/neuonc/nov143; PMCID=PMC4767234
Brad Davis, Yao-Qing Shen, Candice C. Poon, Hema Artee Luchman, Owen D.M. Stechishin, Carly Sabine Pontifex, Wei Wu, John J.P. Kelly, Michael D. Blough;
Terry Fox Research Institute Glioblastoma Consortium
Comparative genomic and genetic analysis of glioblastoma-derived brain tumor-initiating cells and their parent tumors.
Neuro-oncol. 18:350-360(2016)

PubMed=30153289; DOI=10.1371/journal.pone.0202860; PMCID=PMC6112648
Alice L. Yuan, Christian B. Ricks, Alexandra K. Bohm, Xue-Qing Lun, Lori Maxwell, Shahana Safdar, Shazreh Bukhari, Amanda Gerber, Wajid Sayeed, Elizabeth Ann Bering, Haley Pedersen ...Show all 26 authors... , Jennifer Ai-Wen Chan, Yao-Qing Shen, Marco Antonio Marra, David Ross Kaplan, Warren P. Mason, Lindsey Dale Goodman, Ravesanker Ezhilarasan, Ascher B. Kaufmann, Matthew Cabral, Stephen M. Robbins, Donna L. Senger, Daniel P. Cahill, Erik P. Sulman, J. Gregory Cairncross, Michael D. Blough; Show fewer authors
ABT-888 restores sensitivity in temozolomide resistant glioma cells and xenografts.
PLoS ONE 13:e0202860.1-e0202860.18(2018)